FDA Inspection
Phase 4 Pharmaceutical LlcPhase 4 Pharmaceutical Llc – FDA Inspection, May 2, 2017
Record Details
This FDA Inspection record concerns Phase 4 Pharmaceutical Llc, with an inspection on May 2, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d3ef30be-739a-4d9b-bb71-06523085f673
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1010074
- FDA center
- Human Drugs
- Project area
- Unapproved and Misbranded Drugs
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.198(a)Procedures to be written and followed
- 21 CFR 211.204Returned drug procedures in writing and followed
- 21 CFR 211.142Written warehousing procedures established/followed
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.150Written distribution procedure
- 21 CFR 211.180(e)(2)Items to cover on annual reviews
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Phase 4 Pharmaceutical Llc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 15, 2015 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
Other documents for Phase 4 Pharmaceutical Llc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.